BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 16280370)

  • 1. Angiotensin II: a key factor in the inflammatory and fibrotic response in kidney diseases.
    Ruiz-Ortega M; Rupérez M; Esteban V; Rodríguez-Vita J; Sánchez-López E; Carvajal G; Egido J
    Nephrol Dial Transplant; 2006 Jan; 21(1):16-20. PubMed ID: 16280370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin II induces matrix metalloproteinase-9 expression via a nuclear factor-kappaB-dependent pathway in vascular smooth muscle cells.
    Guo RW; Yang LX; Wang H; Liu B; Wang L
    Regul Pept; 2008 Apr; 147(1-3):37-44. PubMed ID: 18252266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin II signal transduction through the AT1 receptor: novel insights into mechanisms and pathophysiology.
    Higuchi S; Ohtsu H; Suzuki H; Shirai H; Frank GD; Eguchi S
    Clin Sci (Lond); 2007 Apr; 112(8):417-28. PubMed ID: 17346243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrin-linked kinase plays a key role in the regulation of angiotensin II-induced renal inflammation.
    Alique M; Civantos E; Sanchez-Lopez E; Lavoz C; Rayego-Mateos S; Rodrigues-Díez R; García-Redondo AB; Egido J; Ortiz A; Rodríguez-Puyol D; Rodríguez-Puyol M; Ruiz-Ortega M
    Clin Sci (Lond); 2014 Jul; 127(1):19-31. PubMed ID: 24383472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative study of ACE inhibitors and angiotensin II receptor antagonists in interstitial scarring.
    Klahr S; Morrissey JJ
    Kidney Int Suppl; 1997 Dec; 63():S111-4. PubMed ID: 9407436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin II upregulates toll-like receptor 4 on mesangial cells.
    Wolf G; Bohlender J; Bondeva T; Roger T; Thaiss F; Wenzel UO
    J Am Soc Nephrol; 2006 Jun; 17(6):1585-93. PubMed ID: 16675600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of diabetes-induced retinal inflammation by blocking the angiotensin II type 1 receptor or its downstream nuclear factor-kappaB pathway.
    Nagai N; Izumi-Nagai K; Oike Y; Koto T; Satofuka S; Ozawa Y; Yamashiro K; Inoue M; Tsubota K; Umezawa K; Ishida S
    Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4342-50. PubMed ID: 17724226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin II, via AT1 and AT2 receptors and NF-kappaB pathway, regulates the inflammatory response in unilateral ureteral obstruction.
    Esteban V; Lorenzo O; Rupérez M; Suzuki Y; Mezzano S; Blanco J; Kretzler M; Sugaya T; Egido J; Ruiz-Ortega M
    J Am Soc Nephrol; 2004 Jun; 15(6):1514-29. PubMed ID: 15153562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin II type 2 receptor provides an endogenous brake during inflammation-induced microvascular fluid leak.
    Ereso AQ; Ramirez RM; Sadjadi J; Cripps MW; Cureton EL; Curran B; Victorino GP
    J Am Coll Surg; 2007 Oct; 205(4):527-33. PubMed ID: 17903725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal and vascular hypertension-induced inflammation: role of angiotensin II.
    Ruiz-Ortega M; Esteban V; Rupérez M; Sánchez-López E; Rodríguez-Vita J; Carvajal G; Egido J
    Curr Opin Nephrol Hypertens; 2006 Mar; 15(2):159-66. PubMed ID: 16481883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The regulation of the inflammatory response through nuclear factor-kappab pathway by angiotensin IV extends the role of the renin angiotensin system in cardiovascular diseases.
    Ruiz-Ortega M; Esteban V; Egido J
    Trends Cardiovasc Med; 2007 Jan; 17(1):19-25. PubMed ID: 17210474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Rho-kinase pathway regulates angiotensin II-induced renal damage.
    Rupérez M; Sánchez-López E; Blanco-Colio LM; Esteban V; Rodríguez-Vita J; Plaza JJ; Egido J; Ruiz-Ortega M
    Kidney Int Suppl; 2005 Dec; (99):S39-45. PubMed ID: 16336575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intra-renal angiotensin II/AT1 receptor, oxidative stress, inflammation, and progressive injury in renal mass reduction.
    Vaziri ND; Bai Y; Ni Z; Quiroz Y; Pandian R; Rodriguez-Iturbe B
    J Pharmacol Exp Ther; 2007 Oct; 323(1):85-93. PubMed ID: 17636006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EPA and DHA suppress AngII- and arachidonic acid-induced expression of profibrotic genes in human mesangial cells.
    Priante G; Musacchio E; Valvason C; Baggio B
    J Nephrol; 2009; 22(1):137-43. PubMed ID: 19229829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin II type 1 receptor-dependent nuclear factor-kappaB activation-mediated proinflammatory actions in a rat model of obstructive acute pancreatitis.
    Chan YC; Leung PS
    J Pharmacol Exp Ther; 2007 Oct; 323(1):10-8. PubMed ID: 17616560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term treatment with an ACE inhibitor or an AT1 antagonist avoids hypertension-induced inflammation in the kidney.
    Esteban V; Gallego-Delgado J; Lazaro A; Osende J; Mezzano S; Egido J; Ruiz-Ortega M
    J Nephrol; 2006; 19(6):725-31. PubMed ID: 17173244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of angiotensin II receptors levels during rat induced pulpitis.
    Souza PP; Fukada SY; Cunha FQ; Costa CA; Costa-Neto CM
    Regul Pept; 2007 Apr; 140(1-2):27-31. PubMed ID: 17197045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type 1 angiotensin receptor (AT1-R)-mediated decrease in type 2 angiotensin receptor mRNA level is dependent on Gq and extracellular signal-regulated kinase 1//2 in AT1-R-transfected PC12 cells.
    Saito M; Shinohara Y; Sasaki H; Netsu Y; Yoshida M; Nakahata N
    J Neuroendocrinol; 2008 Mar; 20(3):299-308. PubMed ID: 18208547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin II and Aldosterone stimulating NF-kappaB and AP-1 activation in hepatic fibrosis of rat.
    Li X; Meng Y; Wu P; Zhang Z; Yang X
    Regul Pept; 2007 Jan; 138(1):15-25. PubMed ID: 16971004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peroxisome proliferator-activated receptor-gamma agonists attenuate angiotensin II-induced collagen type I expression in adventitial fibroblasts.
    Zhang J; Fang NY; Gao PJ; Wu LY; Han WQ; Guo SJ; Shen WL; Zhu DL
    Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):72-7. PubMed ID: 18047631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.